ZALTRAP® Indications
Combined with 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI regimen) for the treatment of:
• Adult patients with metastatic colorectal cancer (mCRC) resistant to or progressing on an oxaliplatin-containing regimen
• Disease progression must be confirmed during or within 6 months after completion of oxaliplatin-containing therapy
Let us work together to protect precious health